None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy female subjects, as determined from a recent medical history. 2. Subjects in the age group of 35-60 years (both ages inclusive) 3. Subjects with all skin types (preferably in equal ratio). 4. Subjects with dull-looking skin. 5. Subjects who have not used retinol-based products minimum 8 weeks prior to enrollment (only for group 2). 6. Subjects with fine lines around the eyes (only for group 2) 7. Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face. 8. Subjects who agree not to use any other product/treatment/home remedy/soap bar on their face during the study period other than the test products. 9. Subjects must not be using any other skin-brightening products, or topical treatments during the study period (mandatory for group 4). 10. Subjects who agree not to carry out bleaching or any other procedures including facial etc. on face during the study period. 11. Subjects who agree not to expose to excessive sunlight. (Sun exposure not more than half an hour daily and during that time use of umbrella to cover face). 12. Subjects willing to give voluntary written informed consent and agree to come for regular follow-up.
Exclusion criteria
Exclusion criteria: 1. A known history or present condition of an allergic response to any cosmetic products. 2. Subject having active skin diseases (e.g., active atopic dermatitis, pigmented contact dermatitis or other cutaneous manifestations), which will interfere with the assessment. 3. Subjects who have sensitivity towards products containing AHA/BHA or Vit C or Retinol components. 4. Subjects had cancer in the last 10 years 5. Subjects with wounds, sunburn, scars, tattoos or piercings at the skin test site(s) 6. Subjects with application of ointments, creams etc. for antibacterial, anti-allergic or immunosuppressive treatment of the skin at the test site(s) 7. History of intense sun exposure and/ photo toxicity/allergy. 8. Female subjects who are pregnant, lactating or nursing. 9. Chronic illness which may influence the cutaneous state. 10. Subject participating in any other cosmetic or therapeutic trial. 11. Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) the deep moisturization benefit between groups as well as against the baseline,using dermatological and instrumental assessments. 2) the antiaging benefit between groups as well as against the baseline,using dermatological and instrumental assessments. 3) the exfoliation benefits between groups as well as against the baseline,using dermatological and instrumental assessments. 4) the brightening effect between groups as well as against the baseline,using dermatological and instrumental assessments. Timepoint: baseline, weeks 1,2,4 and 8 | — |
Secondary
| Measure | Time frame |
|---|---|
| the efficacy of test products using subject self-assessment.Timepoint: 8 weeks | — |
Countries
India
Contacts
MS Clinical research